What dose of Wegovy is most effective — and does higher always mean better?

The myth: the highest dose is automatically the most effective dose for everyone

This is the misconception worth correcting first. People searching for the most effective Wegovy dose often assume the answer is simply "the highest one" and try to reach it quickly. The evidence tells a more nuanced story.

Wegovy's titration schedule exists for a clinical reason, not a bureaucratic one. The body needs time to adapt to GLP-1 receptor agonism, gastric emptying slows, appetite signals shift, and nausea is common early on. Dose increases that happen too quickly tend to produce side effects severe enough to force a pause or a step back, which interrupts the treatment progression entirely. The prescriber's job is to find the highest dose you tolerate well, because that is where you get the best sustained result, and sustained is the operative word.

Some patients achieve meaningful weight loss at 1.7mg and tolerate 2.4mg poorly. Others move through the schedule without a problem and reach 2.4mg on the standard timeline. Neither pattern is a failure; both are part of how the medicine works in practice. You can read more about how the dose levels compare across the schedule on our Wegovy doses overview.

The short version: for most people, 2.4mg weekly is where the strongest and best-evidenced weight loss occurs. But "most effective" means most effective for you, at a dose you can actually stay on.

What the STEP 1 trial data shows about the 2.4mg maintenance dose

The headline figure (roughly 15% average weight reduction over 68 weeks) comes from STEP 1, a placebo-controlled trial of once-weekly semaglutide 2.4mg alongside lifestyle changes, published in the New England Journal of Medicine. Around 1,961 adults with obesity or overweight plus at least one weight-related condition took part.

That 15% average is meaningful. To put it in context, a person starting at 100kg would see roughly 15kg of reduction at the trial average, though individual results vary considerably above and below that figure. If you are wondering what dose of Wegovy is effective and how the titration targets are determined, the trial used 2.4mg as the maintenance target, reached through the standard titration starting at 0.25mg.

One practical detail worth knowing: Wegovy pens are refrigerated. Many patients keep the current pen in the fridge door, easy to grab on injection day, away from items that might freeze it. Storage instructions in your patient information leaflet govern the exact temperature window, and your prescriber or pharmacist can walk you through it if you have questions.

The NHS medicines page for semaglutide carries patient-level information on what to expect during treatment, including how side effects typically behave at different points in the titration.

The 7.2mg dose: newer MHRA-approved option and what its trial data shows

In January 2026 the MHRA approved 7.2mg semaglutide as a higher maintenance dose for Wegovy, and on 14 April 2026 the regulator approved a dedicated single-dose 7.2mg pen. This approval applies to adults with a BMI of 30 or above, it is not indicated for lower BMI or for the cardiovascular indication.

Trial data for 7.2mg puts average weight loss at around 20.7% over 72 weeks. That figure begins to close the gap with higher-dose tirzepatide results, and it changes how the question "what semaglutide dose is most effective" is answered at a population level. The 7.2mg dose is reached via the same gradual titration that starts at 0.25mg, and understanding whether 0.25mg semaglutide is doing anything useful in those early weeks can help set realistic expectations for that initial stage.

For anyone considering whether the newer dose changes their options, that is a conversation for your prescriber. Specific dose availability is confirmed at consultation, not before. If you want to understand how the two licensed GLP-1 medicines compare more broadly, our weight-loss treatment overview covers the landscape without prescription-specific detail.

It is also worth noting that the most effective semaglutide dose at a population level and the right dose for an individual are not always the same thing. Prescribers look at your starting weight, any relevant conditions, how you tolerated earlier doses, and whether you are still losing weight on your current dose before recommending any change.

How dose decisions are made in practice, and what this means if you're considering private treatment

A prescriber looking at your Wegovy dose is weighing several things at once: current weight and trajectory, side-effect burden, any conditions that affect tolerability, and whether the evidence supports continuing to titrate. NICE's appraisal of semaglutide for weight management, TA875, notes that treatment should be reviewed if less than 5% weight loss has occurred after 6 months at the maintenance dose, a signal that individual response matters as much as dose level. Patients who are still on the second step of the schedule sometimes ask whether 0.5mg Wegovy is effective enough to produce noticeable results, and the clinical picture at that stage is worth understanding before drawing conclusions.

On the NHS, Wegovy is available through specialist weight management services under strict eligibility criteria, with waiting lists that vary by area. Private routes exist for people who do not meet NHS thresholds or prefer not to wait. You can explore how to access Wegovy through a private prescriber and what that process involves. What a maintenance dose looks like in practice (and what happens when you reach it) is covered in detail on our maintenance dose page.

At the end of all of this, the most effective Wegovy dose is the highest dose you can tolerate consistently, reached at a pace that keeps side effects manageable. Getting there takes clinical oversight, not guesswork. If you want our prescribers to assess whether Wegovy is suitable for you, check your eligibility with a free consultation.